178 related articles for article (PubMed ID: 24976992)
1. Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.
Liang Y; He L; Yuan H; Jin Y; Yao Y
J Thorac Dis; 2014 Jun; 6(6):694-705. PubMed ID: 24976992
[TBL] [Abstract][Full Text] [Related]
2. Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis.
Fan XY; Hu XL; Han TM; Wang NN; Zhu YM; Hu W; Ma ZH; Zhang CJ; Xu X; Ye ZY; Han CM; Pan WS
BMC Gastroenterol; 2011 Aug; 11():92. PubMed ID: 21867527
[TBL] [Abstract][Full Text] [Related]
3. Runt-related Transcription Factor 3 Promoter Hypermethylation and Gastric Cancer Risk: A Meta-analysis.
Lina M; Changan W; Qing Z
Open Life Sci; 2018 Jan; 13():64-70. PubMed ID: 33817069
[TBL] [Abstract][Full Text] [Related]
4. Association of promoter methylation of RUNX3 gene with the development of esophageal cancer: a meta analysis.
Wang Y; Qin X; Wu J; Qi B; Tao Y; Wang W; Liu F; Li H; Zhao B
PLoS One; 2014; 9(9):e107598. PubMed ID: 25229459
[TBL] [Abstract][Full Text] [Related]
5. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data.
Liu WJ; Tan XH; Guo BP; Ke Q; Sun J; Cen H
Asian Pac J Cancer Prev; 2013; 14(6):3719-24. PubMed ID: 23886171
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.
Xu L; Lan H; Su Y; Li J; Wan J
Drug Des Devel Ther; 2015; 9():2855-65. PubMed ID: 26082616
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis.
Zhang X; He H; Zhang X; Guo W; Wang Y
Cancer Invest; 2015 Apr; 33(4):121-5. PubMed ID: 25664646
[TBL] [Abstract][Full Text] [Related]
8. Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis.
Gu C; Lu J; Cui T; Lu C; Shi H; Xu W; Yuan X; Yang X; Huang Y; Lu M
PLoS One; 2013; 8(9):e72633. PubMed ID: 24086261
[TBL] [Abstract][Full Text] [Related]
9. The association between runt-related transcription factor 3 gene promoter methylation and gastric cancer: A meta-analysis.
Liu X; Wang L; Guo Y
J Cancer Res Ther; 2016 Oct; 12(Supplement):50-53. PubMed ID: 27721253
[TBL] [Abstract][Full Text] [Related]
10. Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer.
Yu GP; Ji Y; Chen GQ; Huang B; Shen K; Wu S; Shen ZY
Oncol Lett; 2012 Jan; 3(1):159-162. PubMed ID: 22740873
[TBL] [Abstract][Full Text] [Related]
11. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
Liu F; Lu X; Zhou X; Huang H
Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
[TBL] [Abstract][Full Text] [Related]
12. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer].
Wei H; Fang N; Guo L; Wu Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis.
Shou F; Xu F; Li G; Zhao Z; Mao Y; Yang F; Wang H; Guo H
Onco Targets Ther; 2017; 10():247-257. PubMed ID: 28123306
[TBL] [Abstract][Full Text] [Related]
15. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
16. The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
Shao C; Dai W; Li H; Tang W; Jia S; Wu X; Luo Y
PLoS One; 2017; 12(2):e0171676. PubMed ID: 28207831
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
18. [RUNX3 promoter hypermethylation and prognosis of early surgically resected non-small cell lung cancers].
Tang Y; Wu F; Hu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):650-4. PubMed ID: 21873791
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
[TBL] [Abstract][Full Text] [Related]
20. Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis.
Huang YZ; Wu W; Wu K; Xu XN; Tang WR
Asian Pac J Cancer Prev; 2014; 15(23):10325-8. PubMed ID: 25556469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
